Teratogen update: fetal effects of indomethacin administration during pregnancy.
Norton
M E
ME
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
D000328:Adult; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005314:Embryonic and Fetal Development / Q000187:drug effects* / Q000502:physiology; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects*; D011247:Pregnancy / Q000187:drug effects* / Q000378:metabolism; D011270:Pregnancy, Animal / Q000187:drug effects* / Q000378:metabolism; D011297:Prenatal Exposure Delayed Effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007213:Indomethacin